Outil d'établissement de liens pour le concours de subventions d'équipe Centre national de coordination de données et de ressources biologiques sur le cancer

Le concours de subventions d'équipe vise à mettre en place un centre national de coordination de données et de ressources biologiques sur le cancer à partir des plateformes, initiatives et dépôts existants au Canada, afin de renforcer l'écosystème des données de recherche du pays. Le centre favorisera une approche coordonnée, interconnectée et fiable de l'intendance des données en permettant l'intégration, le couplage et le partage responsable d'atouts importants dans la recherche au Canada.

L'outil d'établissement de liens a vocation à mettre en relation les candidats au concours et à faciliter la formation d'équipes de recherche et l'élaboration des demandes.

Pour être inclus dans l'outil d'établissement de liens, veuillez remplir ce court formulaire. Il peut être rempli par les chercheurs, les utilisateurs des connaissances (c.-à-d. les personnes ayant une expérience concrète, les praticiens et les responsables des politiques) et les partenaires candidats qui souhaitent échanger des renseignements ou établir une collaboration dans le cadre de la possibilité de financement.

L'utilisation de l'outil d'établissement de liens ne constitue pas une exigence du processus de présentation d'une demande et ne procure aucun avantage particulier dans l'évaluation et le financement des demandes. Il n'est donc pas obligatoire de communiquer avec les personnes qui ont rendu leur information publique à l'aide de l'outil.

En remplissant le formulaire, vous consentez à ce que son contenu soit publié tel quelNote en bas de page * dans la langue dans laquelle il a été soumis (français ou anglais). Sachez que vous pouvez à tout moment soumettre une demande de modification ou de retrait de vos renseignements en écrivant à cihr.icr@uhn.ca. Les renseignements fournis seront publiés dans le tableau ci-dessous qui sera mis à jour régulièrement.

N'hésitez pas à adresser toute question au sujet du formulaire ou de l'outil à cihr.icr@uhn.ca.


Avis

L'information est fournie dans la langue dans laquelle le répondant l'a présentée.

Coordonnées Catégorie d'intervenants Domaine de recherche et d'expertise Renseignements complémentaires
Yongjin Park
ypark@bccrc.ca
BC Cancer
Vancouver, BC, Canada
  • Researcher
  • Early Career Researcher
My research focuses on developing AI/ML methods to elucidate the causal relationships among molecular mechanisms in cancer and other complex disorders. More specifically, we design biologically interpretable probabilistic models to find latent patterns in high-dimensional single-cell data. We have expertise in computational biology, statistical genetics, and Bayesian probabilistic inference. We can also participate in many stages of the overall bioinformatics pipeline as well. We established a highly efficient Rust-based ecosystem that enables us to handle any modality, from low- to high-level features. We fully acknowledge that many aspects of healthcare data analysis should be kept in an isolated environment, so we strive to write software that can efficiently and effectively run with limited resources in an agentic manner.
Cheryl Peters
cheryl.peters1@bccdc.ca
Cheryl Peters - School of Population and Public Health
BCCDC, BC Cancer & University of British
Columbia
Victoria, BC, Canada
  • Researcher
Occupational and environmental exposure to carcinogens, as the PI of CAREX Canada. CAREX Canada is the only national source of occupational exposure information on a suite of 50+ carcinogens and it seems like this project opportunity might be able to continue funding the data updating and acquisition for a networked project.
Kelli Buckreus
kelli.buckreus@ualberta.ca
780-293-4587
Dianne and Irving Kipnes Health Research Institute, College of Health Sciences, University of Alberta
Edmonton, AB, Canada
  • Research Operations
Translational health research, learning health systems  
Marilyn Kinloch
mary.kinloch@saskhealthauthority.ca
Canadian Bioinformatics Hub
Canada
  • Researcher
  • Healthcare Provider
Biobanking, genomics, next-generation sequencing, histology, IHC, gynecologic pathology We have a comprehensive cohort of ovarian cancer patients with whole genome sequencing (tumour and germline), and biomarker (IHC) landscape.
Michelle Brazas
mbrazas@oicr.on.ca
Canadian Bioinformatics Hub
Canada
  • Knowledge User
The Canadian Bioinformatics Hub is Canada’s platform for Bioinformatics, Computational Biology, and Data Science skills and community development. The platform is built on the two foundational pillars of Training and Community, both governed by an overarching Inclusion, Diversity, Equity and Accessibility (IDEA) Framework. Training and community resources are regionally distributed by six centers across the country, supporting capacity growth in talent according to local needs. The aim is to support the growth of a vibrant health and life sciences sector in Canada by scaling up Bioinformatics, Computational Biology, and Data Science (BCBDS) capacity. As a Bioinformatics, Computational Biology, and Data Science (BCBDS) training platform, we have Regional Coordinators who can help facilitate workshop development and delivery in a region or nationally. We are open to delivering from our workshop portfolio or co-developing or co-branding short format workshops for your project audience or beyond. We have been operational in Canada since 1999, and have trained over 5500+ trainees.
Anne Hayes
anne.hayes@hdrn.ca
Health Data Research Network Canada (HDRN Canada)
Toronto, ON, Canada
  • National health data access and research support organization
HDRN Canada Data Services facilitates access to health and health-related data for multi-regional research across Canada. Our expertise includes feasibility assessments, and support for data access and linkage, harmonization, and distributed analysis. Through HDRN Canada, researchers can request access to almost 600 linkable data assets held by data centres across 10 provinces, 2 territories, CIHI and Statistics Canada, including the Alberta Cancer Registry (AB), Manitoba Cancer Registry and Treatment (MB), NB Breast Cancer Screening (NB), and Saskatchewan Cancer Registry Dataset (SK). HDRN Canada Data Services provides a single point of access for multi-regional studies. Researchers submit one data access request and are supported by our team of data scientists, project managers, data access coordinators and analysts throughout the process. We coordinate with participating data centres to streamline multiregional-specific approvals and requirements, reducing administrative burden for research teams. Support is available from early study planning and feasibility through data access and analysis.
Muhammad Habibullah Khan
habib.khan@saskcancer.ca
Saskatchewan Cancer Agency
Regina, Saskatchewan, Canada
  • Researcher
  • Healthcare Provider
  • Decision and/or Policymaker
I am a Radiation Oncologist and Medical Director of Quality, Safety and Disease Site Groups at the Saskatchewan Cancer Agency. My clinical and research interests focus on precision oncology, quality improvement, cancer care pathway optimization, real-world outcomes research, AI-enabled clinical decision support, and molecular and genomic testing. I have extensive experience in radiation oncology, systemic therapy integration, multidisciplinary cancer care, clinical governance, and the development of evidence-based provincial standards and oncology care pathways I am interested in building national collaborations in precision oncology, real-world evidence, AI-enabled clinical decision support, and cancer data integration. I can contribute expertise in multidisciplinary cancer care, quality improvement, clinical pathway development, and provincial oncology leadership. Saskatchewan's integrated cancer system offers opportunities for harmonized clinical, imaging, pathology, genomic, and outcomes research to advance precision medicine and improve cancer outcomes across Canada.
Angela M Crawley
acrawley@ohri.ca
613-737-8673
Canadian Biobank Association | Association Canadienne des Biobanque
Ottawa Hospital Research Institute (OHRI)
Ottawa, ON, Canada
  • Researcher
As Director of the Canadian Biobank Alliance (CBA), I have been leading the design and growth of a national biobank network system. We specialize in biospecimen collection storage and distribution, are actively innovating in the necessary bioethics and contractual frameworks for a nationally integrated resource sharing network and we provide an access point, through our national catalog, to improve biospecimen discoverability and access to the research community in academia, government and industry. The Canadian Biobank Alliance is interested in partnering with groups and leaders interested in the National Cancer Data and Bio-Resource Coordinating Hub opportunity. We have developed a national catalog, accessible by the research community, to peruse a growing inventory of biospecimens, in a disease agnostic manner. We are looking for partners with a strong cancer data platform that would complement our infrastructure. Interested partners: please contact us for an information meeting with the CBA to explore potential collaboration and mutual alignment. info@cba-acb.ca
Heather Ruff
heather.ruff@saskhealthauthority.ca
306-471-6509
Saskatchewan Health Authoriy & University of Saskatoon
Saskatoon, SK, Canada
  • Researcher
  • Healthcare Provider
  • Pathologist
Validation of biomarker testing on Cytopathology specimens I would like to work on improving cytopathology services and establishing/improving rapid on-site evaluation services for specimen collection for cancer diagnostic and prognostic testing (FNA and biopsy; palpable, US-guided, CT-guided, EBUS, EUS, etc). I would also like to work expand biomarker testing to enable it to be done on smaller samples like cytology samples and specimen derivatives like supernatant. Additionally, I would like to work to establish a route whereby new biomarker testing recommendations are more rapidly assess and integrated into funded testing at the national or provincial level so that both testing and treatment availability is more equitable and new therapies are available faster.
Date de modification :